In-silico Approaches to Study Therapeutic Efficacy of Nutraceuticals

Medicinal plants are sources of bioactive compounds for curing ailments since ages. In absence of modern analytical techniques during earlier period, characterization of plant bioactive metabolites was a difficult task, which has now become possible with the innovation in analytical methods. The emerging databases of medicinal plants rich in phytochemical data with bioinformatics and cheminformatics techniques have shown to be advantageous tools for drug discovery. Owing to rising trend of bioactivity databases, the practice of using computational tools for prediction of protein targets of small molecules has been showing advancement. Speedy progressions in computational technologies have significantly accelerated the development of computer-aided drug design. Recently, pharmaceutical sector has gradually shifted its attention towards traditional system of medicine for getting insight into novel lead compounds and directed their efforts towards 3D small molecular structure database available for molecular simulation or virtual screening. In this chapter an attempt has been made to discuss existing methods for target prediction based on the bioactivity information from the ligand side as well as the methods that are applicable in circumstances when the structure of a protein is known. The detailed account of in silico target identification applications based partly/whole on computational target predictions has been described.

[1]  S. Chattopadhyay,et al.  QSAR, docking and in vitro studies for anti-inflammatory activity of cleomiscosin A methyl ether derivatives. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  D. Weaver,et al.  The rise of micropharma. , 2010, Drug discovery today.

[3]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[4]  Luis G Valerio Application of advanced in silico methods for predictive modeling and information integration , 2012, Expert opinion on drug metabolism & toxicology.

[5]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[6]  Pantelis Sopasakis,et al.  Collaborative development of predictive toxicology applications , 2010, J. Cheminformatics.

[7]  S. Khanum,et al.  Design, Synthesis, and Anticancer Properties of Novel Benzophenone‐Conjugated Coumarin Analogs , 2013, Archiv der Pharmazie.

[8]  D. Yadav,et al.  QSAR, docking and in vivo studies for immunomodulatory activity of isolated triterpenoids from Eucalyptus tereticornis and Gentiana kurroo. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  Jörg Lippert,et al.  From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools , 2005, Expert opinion on drug metabolism & toxicology.

[10]  D. Kroll,et al.  Herbs as medicines. , 1998, Archives of internal medicine.

[11]  G. Joksiċ,et al.  Inhibition of Vascular Smooth Muscle Cell Proliferation by Gentiana lutea Root Extracts , 2013, PloS one.

[12]  Santiago Vilar,et al.  Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. , 2008, Current topics in medicinal chemistry.

[13]  Feroz Khan,et al.  QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum. , 2012, Current pharmaceutical design.

[14]  Hazem A. Ghabbour,et al.  Synthesis and Cytotoxic Activity of Biphenylurea Derivatives Containing Indolin-2-one Moieties , 2016, Molecules.

[15]  Edward H. Kerns,et al.  Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization , 2008 .

[16]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[17]  Feroz Khan,et al.  Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity , 2012, Journal of Molecular Modeling.

[18]  Feroz Khan,et al.  In Silico Exploration of Anti‐Inflammatory Activity of Natural Coumarinolignoids , 2011, Chemical biology & drug design.

[19]  F. Leendertz,et al.  Clinical and pathologic manifestation of oesophagostomosis in African great apes: does self‐medication in wild apes influence disease progression? , 2008, Journal of medical primatology.

[20]  P. Xiao,et al.  In silico Approach for Anti-Thrombosis Drug Discovery: P2Y1R Structure-Based TCMs Screening , 2017, Front. Pharmacol..

[21]  Fan Yi,et al.  In silico approach in reveal traditional medicine plants pharmacological material basis , 2018, Chinese Medicine.

[22]  U. Schippmann,et al.  Impact of cultivation and gathering of medicinal plants on biodiversity: global trends and issues. , 2003 .

[23]  M. Zehl,et al.  Catechol alkenyls from Semecarpus anacardium: acetylcholinesterase inhibition and binding mode predictions. , 2012, Journal of ethnopharmacology.

[24]  K. Vaishnavi,et al.  Differential Activities of the Two Closely Related Withanolides, Withaferin A and Withanone: Bioinformatics and Experimental Evidences , 2012, PloS one.

[25]  P. Suryanarayana,et al.  The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis , 2012, PloS one.

[26]  Q. Do,et al.  Reverse Pharmacognosy: Application of Selnergy, a New Tool for Lead Discovery. The Example of ε-Viniferin , 2005 .

[27]  Shufeng Zhou,et al.  New perspectives on complementary and alternative medicine: an overview and alternative therapy. , 2012, Alternative therapies in health and medicine.

[28]  S. Aishwarya,et al.  Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis , 2011, Bioinformation.

[29]  Dilip Kumar Singh,et al.  Characterization of stress degradation products of amodiaquine dihydrochloride by liquid chromatography with high-resolution mass spectrometry and prediction of their properties by using ADMET Predictor™. , 2017, Journal of separation science.

[30]  S. Janssen,et al.  Dosed without prescription: a framework for preventing pharmaceutical contamination of our nation's drinking water. , 2011, Environmental science & technology.

[31]  Feroz Khan,et al.  Development of QSAR model for immunomodulatory activity of natural coumarinolignoids , 2010, Drug design, development and therapy.

[32]  Vladimir V Poroikov,et al.  Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review. , 2014, Natural product reports.

[33]  Sujata Sharma,et al.  Saponins as novel TNF-alpha inhibitors: isolation of saponins and a nor-pseudoguaianolide from Parthenium hysterophorus. , 2009, Organic & biomolecular chemistry.

[34]  Wei Zhao,et al.  Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy , 2016, Front. Pharmacol..

[35]  Thomas Lengauer,et al.  Computational methods for biomolecular docking. , 1996, Current opinion in structural biology.

[36]  C. Ung,et al.  Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? , 2003, Natural product reports.

[37]  V. Sommer,et al.  Leaf-swallowing in Nigerian chimpanzees: evidence for assumed self-medication , 2006, Primates.